150 related articles for article (PubMed ID: 18491217)
1. Quality of life valuations of mammography screening.
Bonomi AE; Boudreau DM; Fishman PA; Ludman E; Mohelnitzky A; Cannon EA; Seger D
Qual Life Res; 2008 Jun; 17(5):801-14. PubMed ID: 18491217
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk, worry, and anxiety: Effect on patient perceptions of false-positive screening results.
Lee JM; Lowry KP; Cott Chubiz JE; Swan JS; Motazedi T; Halpern EF; Tosteson ANA; Gazelle GS; Donelan K
Breast; 2020 Apr; 50():104-112. PubMed ID: 32135458
[TBL] [Abstract][Full Text] [Related]
3. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
Kerlikowske K; Salzmann P; Phillips KA; Cauley JA; Cummings SR
JAMA; 1999 Dec; 282(22):2156-63. PubMed ID: 10591338
[TBL] [Abstract][Full Text] [Related]
4. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
[TBL] [Abstract][Full Text] [Related]
5. A cost utility analysis of mammography screening in Australia.
Hall J; Gerard K; Salkeld G; Richardson J
Soc Sci Med; 1992 May; 34(9):993-1004. PubMed ID: 1631612
[TBL] [Abstract][Full Text] [Related]
6. Retrospective cost-effectiveness analysis of screening mammography.
Stout NK; Rosenberg MA; Trentham-Dietz A; Smith MA; Robinson SM; Fryback DG
J Natl Cancer Inst; 2006 Jun; 98(11):774-82. PubMed ID: 16757702
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing elderly women's mammography screening decisions: implications for counseling.
Schonberg MA; McCarthy EP; York M; Davis RB; Marcantonio ER
BMC Geriatr; 2007 Nov; 7():26. PubMed ID: 18021402
[TBL] [Abstract][Full Text] [Related]
8. Change in health-related quality of life in older women after diagnosis of a small breast cancer.
Euhus DM; Addae JK; Snyder CF; Canner JK
Cancer; 2019 Jun; 125(11):1807-1814. PubMed ID: 30707774
[TBL] [Abstract][Full Text] [Related]
9. Mammography screening after breast cancer diagnosis in a first degree female relative: age group differences (United States).
Lemon SC; Zapka JG; Clemow L; Estabrook B; Fletcher K
Cancer Causes Control; 2006 Oct; 17(8):1053-65. PubMed ID: 16933056
[TBL] [Abstract][Full Text] [Related]
10. Women's views on breast cancer risk and screening mammography: a qualitative interview study.
Silverman E; Woloshin S; Schwartz LM; Byram SJ; Welch HG; Fischhoff B
Med Decis Making; 2001; 21(3):231-40. PubMed ID: 11386630
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(15):1-71. PubMed ID: 27468326
[TBL] [Abstract][Full Text] [Related]
12. Swiss Medical Board Mammography screening predictions for Switzerland: importance of time-periods.
de Koning HJ; Heijnsdijk EA
J Med Screen; 2015 Dec; 22(4):201-6. PubMed ID: 26018779
[TBL] [Abstract][Full Text] [Related]
13. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
[TBL] [Abstract][Full Text] [Related]
14. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
Ringash J;
CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
[TBL] [Abstract][Full Text] [Related]
15. Use of Screening Mammography to Detect Occult Malignancy in Autologous Breast Reconstructions: A 15-year Experience.
Noroozian M; Carlson LW; Savage JL; Jeffries DO; Joe AI; Neal CH; Patterson SK; Hadjiiski LM; Helvie MA
Radiology; 2018 Oct; 289(1):39-48. PubMed ID: 30129903
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population.
Moore SG; Shenoy PJ; Fanucchi L; Tumeh JW; Flowers CR
BMC Health Serv Res; 2009 Jan; 9():9. PubMed ID: 19144138
[TBL] [Abstract][Full Text] [Related]
18. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
19. Breast Screening Utilization and Cost Sharing Among Employed Insured Women After the Affordable Care Act.
Carlos RC; Fendrick AM; Kolenic G; Kamdar N; Kobernik E; Bell S; Dalton VK
J Am Coll Radiol; 2019 Jun; 16(6):788-796. PubMed ID: 30833168
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
